{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:32:27Z","timestamp":1762299147791,"version":"3.37.3"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T00:00:00Z","timestamp":1574121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Enterohemorrhagic <jats:italic>E. coli<\/jats:italic> (EHEC) is a major cause of large outbreaks worldwide associated with hemorrhagic colitis and hemolytic uremic syndrome. While vaccine development is warranted, a licensed vaccine, specific for human use, against EHEC is not yet available. In this study, the reverse vaccinology approach combined with genomic, transcriptional and molecular epidemiology data was applied on the EHEC O157:H7 genome to select new potential vaccine candidates. Twenty-four potential protein antigens were identified and one of them (MC001) was successfully expressed onto Generalized Modules for Membrane Antigens (GMMA) delivery system. GMMA expressing this vaccine candidate was immunogenic, raising a specific antibody response. Immunization with the MC001 candidate was able to reduce the bacterial load of EHEC O157:H7 strain in feces, colon and caecum tissues after murine infection. MC001 is homologue to lipid A deacylase enzyme (LpxR), and to our knowledge, this is the first study describing it as a potential vaccine candidate. Gene distribution and sequence variability analysis showed that MC001 is present and conserved in EHEC and in enteropathogenic <jats:italic>E. coli<\/jats:italic> (EPEC) strains. Given the high genetic variability among and within <jats:italic>E. coli<\/jats:italic> pathotypes, the identification of such conserved antigen suggests that its inclusion in a vaccine might represent a solution against major intestinal pathogenic strains.<\/jats:p>","DOI":"10.1038\/s41598-019-53197-z","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T11:04:13Z","timestamp":1574161453000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli"],"prefix":"10.1038","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7710-2572","authenticated-orcid":false,"given":"Maricarmen","family":"Rojas-Lopez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manuele","family":"Martinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Brandi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gr\u00e9gory","family":"Jubelin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabio","family":"Polticelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Soriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariagrazia","family":"Pizza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Micka\u00ebl","family":"Desvaux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Rosini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,11,19]]},"reference":[{"key":"53197_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/nrmicro818","volume":"2","author":"JB Kaper","year":"2004","unstructured":"Kaper, J. B., Nataro, J. P. & Mobley, H. L. Pathogenic Escherichia coli. Nat Rev Microbiol 2, 123\u2013140, https:\/\/doi.org\/10.1038\/nrmicro818 (2004).","journal-title":"Nat Rev Microbiol"},{"key":"53197_CR2","doi-asserted-by":"publisher","unstructured":"Moriel, D. G. et al. Escherichia coli: great diversity around a common core. MBio 3, https:\/\/doi.org\/10.1128\/mBio.00118-12 (2012).","DOI":"10.1128\/mBio.00118-12"},{"key":"53197_CR3","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1128\/CMR.00022-13","volume":"26","author":"MA Croxen","year":"2013","unstructured":"Croxen, M. A. et al. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev 26, 822\u2013880, https:\/\/doi.org\/10.1128\/CMR.00022-13 (2013).","journal-title":"Clin Microbiol Rev"},{"key":"53197_CR4","doi-asserted-by":"crossref","unstructured":"Rivas, M., Chinen, I. & Guth, B. E. C. In Escherichia coli in the Americas (ed. Alfredo G. Torres) 97\u2013123 (Springer International Publishing, 2016).","DOI":"10.1007\/978-3-319-45092-6_5"},{"key":"53197_CR5","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1016\/S0140-6736(05)71144-2","volume":"365","author":"PI Tarr","year":"2005","unstructured":"Tarr, P. I., Gordon, C. A. & Chandler, W. L. Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365, 1073\u20131086, https:\/\/doi.org\/10.1016\/S0140-6736(05)71144-2 (2005).","journal-title":"Lancet"},{"key":"53197_CR6","doi-asserted-by":"publisher","DOI":"10.1186\/1741-7015-10-12","volume":"10","author":"PN Goldwater","year":"2012","unstructured":"Goldwater, P. N. & Bettelheim, K. A. Treatment of enterohemorrhagic Escherichia coli (EHEC) infection and hemolytic uremic syndrome (HUS). BMC Med 10, 12, https:\/\/doi.org\/10.1186\/1741-7015-10-12 (2012).","journal-title":"BMC Med"},{"key":"53197_CR7","doi-asserted-by":"publisher","first-page":"81","DOI":"10.3389\/fcimb.2012.00081","volume":"2","author":"AR Pacheco","year":"2012","unstructured":"Pacheco, A. R. & Sperandio, V. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2, 81, https:\/\/doi.org\/10.3389\/fcimb.2012.00081 (2012).","journal-title":"Front Cell Infect Microbiol"},{"key":"53197_CR8","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/nrmicro2265","volume":"8","author":"MA Croxen","year":"2010","unstructured":"Croxen, M. A. & Finlay, B. B. Molecular mechanisms of Escherichia coli pathogenicity. Nat Rev Microbiol 8, 26\u201338, https:\/\/doi.org\/10.1038\/nrmicro2265 (2010).","journal-title":"Nat Rev Microbiol"},{"key":"53197_CR9","doi-asserted-by":"publisher","first-page":"12288","DOI":"10.1073\/pnas.1402981111","volume":"111","author":"R Rappuoli","year":"2014","unstructured":"Rappuoli, R., Pizza, M., Del Giudice, G. & De Gregorio, E. Vaccines, new opportunities for a new society. Proc Natl Acad Sci USA 111, 12288\u201312293, https:\/\/doi.org\/10.1073\/pnas.1402981111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53197_CR10","doi-asserted-by":"publisher","first-page":"440","DOI":"10.3389\/fmicb.2018.00440","volume":"9","author":"M Rojas-Lopez","year":"2018","unstructured":"Rojas-Lopez, M., Monterio, R., Pizza, M., Desvaux, M. & Rosini, R. Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development. Front Microbiol 9, 440, https:\/\/doi.org\/10.3389\/fmicb.2018.00440 (2018).","journal-title":"Front Microbiol"},{"key":"53197_CR11","doi-asserted-by":"publisher","first-page":"2016","DOI":"10.1128\/IAI.01437-13","volume":"82","author":"VA Garcia-Angulo","year":"2014","unstructured":"Garcia-Angulo, V. A., Kalita, A., Kalita, M., Lozano, L. & Torres, A. G. Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. Infect Immun 82, 2016\u20132026, https:\/\/doi.org\/10.1128\/IAI.01437-13 (2014).","journal-title":"Infect Immun"},{"key":"53197_CR12","doi-asserted-by":"publisher","first-page":"94","DOI":"10.3389\/fcimb.2016.00094","volume":"6","author":"D Tapia","year":"2016","unstructured":"Tapia, D. et al. From In silico Protein Epitope Density Prediction to Testing Escherichia coli O157:H7 Vaccine Candidates in a Murine Model of Colonization. Front Cell Infect Microbiol 6, 94, https:\/\/doi.org\/10.3389\/fcimb.2016.00094 (2016).","journal-title":"Front Cell Infect Microbiol"},{"key":"53197_CR13","doi-asserted-by":"publisher","first-page":"1816","DOI":"10.1126\/science.287.5459.1816","volume":"287","author":"M Pizza","year":"2000","unstructured":"Pizza, M. et al. Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science 287, 1816\u20131820 (2000).","journal-title":"Science"},{"key":"53197_CR14","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1126\/science.1109869","volume":"309","author":"D Maione","year":"2005","unstructured":"Maione, D. et al. Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309, 148\u2013150, https:\/\/doi.org\/10.1126\/science.1109869 (2005).","journal-title":"Science"},{"key":"53197_CR15","doi-asserted-by":"publisher","first-page":"9072","DOI":"10.1073\/pnas.0915077107","volume":"107","author":"DG Moriel","year":"2010","unstructured":"Moriel, D. G. et al. Identification of protective and broadly conserved vaccine antigens from the genome of extraintestinal pathogenic Escherichia coli. Proc Natl Acad Sci USA 107, 9072\u20139077, https:\/\/doi.org\/10.1073\/pnas.0915077107 (2010).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53197_CR16","doi-asserted-by":"publisher","first-page":"770","DOI":"10.4161\/19490976.2014.983769","volume":"5","author":"A Kalita","year":"2014","unstructured":"Kalita, A., Kalita, M. & Torres, A. G. Exploiting the power of OMICS approaches to produce E. coli O157 vaccines. Gut Microbes 5, 770\u2013774, https:\/\/doi.org\/10.4161\/19490976.2014.983769 (2014).","journal-title":"Gut Microbes"},{"key":"53197_CR17","doi-asserted-by":"publisher","first-page":"e1004124","DOI":"10.1371\/journal.ppat.1004124","volume":"10","author":"B Nesta","year":"2014","unstructured":"Nesta, B. et al. SslE elicits functional antibodies that impair in vitro mucinase activity and in vivo colonization by both intestinal and extraintestinal Escherichia coli strains. PLoS Pathog 10, e1004124, https:\/\/doi.org\/10.1371\/journal.ppat.1004124 (2014).","journal-title":"PLoS Pathog"},{"key":"53197_CR18","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.vaccine.2018.10.008","volume":"37","author":"I Naili","year":"2019","unstructured":"Naili, I. et al. Mixed mucosal-parenteral immunizations with the broadly conserved pathogenic Escherichia coli antigen SslE induce a robust mucosal and systemic immunity without affecting the murine intestinal microbiota. Vaccine 37, 314\u2013324, https:\/\/doi.org\/10.1016\/j.vaccine.2018.10.008 (2019).","journal-title":"Vaccine"},{"key":"53197_CR19","doi-asserted-by":"publisher","first-page":"12307","DOI":"10.1073\/pnas.1400473111","volume":"111","author":"CA MacLennan","year":"2014","unstructured":"MacLennan, C. A. & Saul, A. Vaccines against poverty. Proc Natl Acad Sci USA 111, 12307\u201312312, https:\/\/doi.org\/10.1073\/pnas.1400473111 (2014).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53197_CR20","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1128\/MMBR.00031-09","volume":"74","author":"TN Ellis","year":"2010","unstructured":"Ellis, T. N. & Kuehn, M. J. Virulence and immunomodulatory roles of bacterial outer membrane vesicles. Microbiol Mol Biol Rev 74, 81\u201394, https:\/\/doi.org\/10.1128\/MMBR.00031-09 (2010).","journal-title":"Microbiol Mol Biol Rev"},{"key":"53197_CR21","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CVI.00119-14","volume":"21","author":"W Nieves","year":"2014","unstructured":"Nieves, W. et al. A Burkholderia pseudomallei outer membrane vesicle vaccine provides protection against lethal sepsis. Clin Vaccine Immunol 21, 747\u2013754, https:\/\/doi.org\/10.1128\/CVI.00119-14 (2014).","journal-title":"Clin Vaccine Immunol"},{"key":"53197_CR22","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.provac.2014.07.007","volume":"8","author":"H Petersen","year":"2014","unstructured":"Petersen, H., Nieves, W., Russell-Lodrigue, K., Roy, C. J. & Morici, L. A. Evaluation of a Burkholderia pseudomallei Outer Membrane Vesicle Vaccine in Nonhuman. Primates. Procedia Vaccinol 8, 38\u201342, https:\/\/doi.org\/10.1016\/j.provac.2014.07.007 (2014).","journal-title":"Primates. Procedia Vaccinol"},{"key":"53197_CR23","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1016\/j.vaccine.2005.01.058","volume":"23","author":"J Holst","year":"2005","unstructured":"Holst, J. et al. The concept of \u201ctailor-made\u201d, protein-based, outer membrane vesicle vaccines against meningococcal disease. Vaccine 23, 2202\u20132205, https:\/\/doi.org\/10.1016\/j.vaccine.2005.01.058 (2005).","journal-title":"Vaccine"},{"issue":"1","key":"53197_CR24","doi-asserted-by":"publisher","first-page":"20181","DOI":"10.3402\/jev.v2i0.20181","volume":"2","author":"Erika Bartolini","year":"2013","unstructured":"Bartolini, E. et al. Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro. J Extracell Vesicles 2, https:\/\/doi.org\/10.3402\/jev.v2i0.20181 (2013).","journal-title":"Journal of Extracellular Vesicles"},{"key":"53197_CR25","doi-asserted-by":"publisher","first-page":"5854","DOI":"10.1128\/AEM.01941-14","volume":"80","author":"MH Daleke-Schermerhorn","year":"2014","unstructured":"Daleke-Schermerhorn, M. H. et al. Decoration of outer membrane vesicles with multiple antigens by using an autotransporter approach. Appl Environ Microbiol 80, 5854\u20135865, https:\/\/doi.org\/10.1128\/AEM.01941-14 (2014).","journal-title":"Appl Environ Microbiol"},{"issue":"1","key":"53197_CR26","doi-asserted-by":"publisher","first-page":"24015","DOI":"10.3402\/jev.v3.24015","volume":"3","author":"Laura Fantappi\u00e8","year":"2014","unstructured":"Fantappie, L. et al. Antibody-mediated immunity induced by engineered Escherichia coli OMVs carrying heterologous antigens in their lumen. J Extracell Vesicles 3, https:\/\/doi.org\/10.3402\/jev.v3.24015 (2014).","journal-title":"Journal of Extracellular Vesicles"},{"key":"53197_CR27","doi-asserted-by":"crossref","first-page":"4872","DOI":"10.1128\/JB.180.18.4872-4878.1998","volume":"180","author":"A Bernadac","year":"1998","unstructured":"Bernadac, A., Gavioli, M., Lazzaroni, J. C., Raina, S. & Lloubes, R. Escherichia coli tol-pal mutants form outer membrane vesicles. J Bacteriol 180, 4872\u20134878 (1998).","journal-title":"J Bacteriol"},{"key":"53197_CR28","doi-asserted-by":"publisher","first-page":"e0134478","DOI":"10.1371\/journal.pone.0134478","volume":"10","author":"C Gerke","year":"2015","unstructured":"Gerke, C. et al. Production of a Shigella sonnei Vaccine Based on Generalized Modules for Membrane Antigens (GMMA), 1790GAHB. PLoS One 10, e0134478, https:\/\/doi.org\/10.1371\/journal.pone.0134478 (2015).","journal-title":"PLoS One"},{"key":"53197_CR29","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.vaccine.2016.11.089","volume":"35","author":"G De Benedetto","year":"2017","unstructured":"De Benedetto, G. et al. Characterization of O-antigen delivered by Generalized Modules for Membrane Antigens (GMMA) vaccine candidates against nontyphoidal Salmonella. Vaccine 35, 419\u2013426, https:\/\/doi.org\/10.1016\/j.vaccine.2016.11.089 (2017).","journal-title":"Vaccine"},{"key":"53197_CR30","doi-asserted-by":"publisher","first-page":"e35616","DOI":"10.1371\/journal.pone.0035616","volume":"7","author":"F Berlanda Scorza","year":"2012","unstructured":"Berlanda Scorza, F. et al. High yield production process for Shigella outer membrane particles. PLoS One 7, e35616, https:\/\/doi.org\/10.1371\/journal.pone.0035616 (2012).","journal-title":"PLoS One"},{"key":"53197_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2164-15-353","volume":"15","author":"R Landstorfer","year":"2014","unstructured":"Landstorfer, R. et al. Comparison of strand-specific transcriptomes of enterohemorrhagic Escherichia coli O157:H7 EDL933 (EHEC) under eleven different environmental conditions including radish sprouts and cattle feces. BMC Genomics 15, 353, https:\/\/doi.org\/10.1186\/1471-2164-15-353 (2014).","journal-title":"BMC Genomics"},{"key":"53197_CR32","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The Protein Data Bank. Nucleic Acids Res 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res"},{"key":"53197_CR33","doi-asserted-by":"publisher","first-page":"1960","DOI":"10.1073\/pnas.0813064106","volume":"106","author":"L Rutten","year":"2009","unstructured":"Rutten, L. et al. Active-site architecture and catalytic mechanism of the lipid A deacylase LpxR of Salmonella typhimurium. Proc Natl Acad Sci USA 106, 1960\u20131964, https:\/\/doi.org\/10.1073\/pnas.0813064106 (2009).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53197_CR34","doi-asserted-by":"publisher","unstructured":"Moriel, D. G. et al. A Novel Protective Vaccine Antigen from the Core Escherichia coli Genome. mSphere 1, https:\/\/doi.org\/10.1128\/mSphere.00326-16 (2016).","DOI":"10.1128\/mSphere.00326-16"},{"key":"53197_CR35","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1016\/j.mib.2006.07.003","volume":"9","author":"M Mora","year":"2006","unstructured":"Mora, M., Donati, C., Medini, D., Covacci, A. & Rappuoli, R. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. Curr Opin Microbiol 9, 532\u2013536, https:\/\/doi.org\/10.1016\/j.mib.2006.07.003 (2006).","journal-title":"Curr Opin Microbiol"},{"issue":"16","key":"53197_CR36","doi-asserted-by":"publisher","first-page":"fnw179","DOI":"10.1093\/femsle\/fnw179","volume":"363","author":"Ricardo Monteiro","year":"2016","unstructured":"Monteiro, R. et al. A secretome view of colonisation factors in Shiga toxin-encoding Escherichia coli (STEC): from enterohaemorrhagic E. coli (EHEC) to related enteropathotypes. FEMS Microbiol Lett 363, https:\/\/doi.org\/10.1093\/femsle\/fnw179 (2016).","journal-title":"FEMS Microbiology Letters"},{"key":"53197_CR37","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1038\/nri3837","volume":"15","author":"M Kaparakis-Liaskos","year":"2015","unstructured":"Kaparakis-Liaskos, M. & Ferrero, R. L. Immune modulation by bacterial outer membrane vesicles. Nat Rev Immunol 15, 375\u2013387, https:\/\/doi.org\/10.1038\/nri3837 (2015).","journal-title":"Nat Rev Immunol"},{"issue":"9","key":"53197_CR38","doi-asserted-by":"publisher","first-page":"2208","DOI":"10.1080\/21645515.2018.1490381","volume":"14","author":"Matias Fingermann","year":"2018","unstructured":"Fingermann, M. et al. OMV-based vaccine formulations against Shiga toxin producing Escherichia coli strains are both protective in mice and immunogenic in calves. Hum Vaccin Immunother, 1\u20136, https:\/\/doi.org\/10.1080\/21645515.2018.1490381 (2018).","journal-title":"Human Vaccines & Immunotherapeutics"},{"key":"53197_CR39","doi-asserted-by":"publisher","first-page":"258185","DOI":"10.1155\/2011\/258185","volume":"2011","author":"KL Mohawk","year":"2011","unstructured":"Mohawk, K. L. & O\u2019Brien, A. D. Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection. J Biomed Biotechnol 2011, 258185, https:\/\/doi.org\/10.1155\/2011\/258185 (2011).","journal-title":"J Biomed Biotechnol"},{"key":"53197_CR40","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.1016\/j.vaccine.2013.05.013","volume":"31","author":"VA Garcia-Angulo","year":"2013","unstructured":"Garcia-Angulo, V. A., Kalita, A. & Torres, A. G. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection. Vaccine 31, 3229\u20133235, https:\/\/doi.org\/10.1016\/j.vaccine.2013.05.013 (2013).","journal-title":"Vaccine"},{"key":"53197_CR41","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbrc.2012.10.054","volume":"428","author":"K Kawasaki","year":"2012","unstructured":"Kawasaki, K., Teramoto, M., Tatsui, R., Amamoto, S. & Lipid, A. 3\u2032-O-deacylation by Salmonella outer membrane enzyme LpxR modulates the ability of lipid A to stimulate Toll-like receptor 4. Biochem Biophys Res Commun 428, 343\u2013347, https:\/\/doi.org\/10.1016\/j.bbrc.2012.10.054 (2012).","journal-title":"Biochem Biophys Res Commun"},{"key":"53197_CR42","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1128\/JB.01449-13","volume":"196","author":"BL Petrone","year":"2014","unstructured":"Petrone, B. L., Stringer, A. M. & Wade, J. T. Identification of HilD-regulated genes in Salmonella enterica serovar Typhimurium. J Bacteriol 196, 1094\u20131101, https:\/\/doi.org\/10.1128\/JB.01449-13 (2014).","journal-title":"J Bacteriol"},{"issue":"1","key":"53197_CR43","doi-asserted-by":"publisher","first-page":"e12806","DOI":"10.1111\/cmi.12806","volume":"20","author":"Rikako Ogawa","year":"2017","unstructured":"Ogawa, R., Yen, H., Kawasaki, K. & Tobe, T. Activation of lpxR gene through enterohaemorrhagic Escherichia coli virulence regulators mediates lipid A modification to attenuate innate immune response. Cell Microbiol, https:\/\/doi.org\/10.1111\/cmi.12806 (2017).","journal-title":"Cellular Microbiology"},{"key":"53197_CR44","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1093\/bioinformatics\/btq249","volume":"26","author":"NY Yu","year":"2010","unstructured":"Yu, N. Y. et al. PSORTb 3.0: improved protein subcellular localization prediction with refined localization subcategories and predictive capabilities for all prokaryotes. Bioinformatics 26, 1608\u20131615, https:\/\/doi.org\/10.1093\/bioinformatics\/btq249 (2010).","journal-title":"Bioinformatics"},{"key":"53197_CR45","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1006\/jmbi.2000.4315","volume":"305","author":"A Krogh","year":"2001","unstructured":"Krogh, A., Larsson, B., von Heijne, G. & Sonnhammer, E. L. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J Mol Biol 305, 567\u2013580, https:\/\/doi.org\/10.1006\/jmbi.2000.4315 (2001).","journal-title":"J Mol Biol"},{"key":"53197_CR46","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1093\/bioinformatics\/bts199","volume":"28","author":"M Kearse","year":"2012","unstructured":"Kearse, M. et al. Geneious Basic: an integrated and extendable desktop software platform for the organization and analysis of sequence data. Bioinformatics 28, 1647\u20131649, https:\/\/doi.org\/10.1093\/bioinformatics\/bts199 (2012).","journal-title":"Bioinformatics"},{"key":"53197_CR47","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"SF Altschul","year":"1997","unstructured":"Altschul, S. F. et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucleic Acids Res 25, 3389\u20133402 (1997).","journal-title":"Nucleic Acids Res"},{"key":"53197_CR48","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/978-1-4939-7015-5_6","volume":"1611","author":"H Nielsen","year":"2017","unstructured":"Nielsen, H. Predicting Secretory Proteins with SignalP. Methods Mol Biol 1611, 59\u201373, https:\/\/doi.org\/10.1007\/978-1-4939-7015-5_6 (2017).","journal-title":"Methods Mol Biol"},{"key":"53197_CR49","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1007\/978-1-59745-196-3_6","volume":"498","author":"HE Klock","year":"2009","unstructured":"Klock, H. E. & Lesley, S. A. The Polymerase Incomplete Primer Extension (PIPE) method applied to high-throughput cloning and site-directed mutagenesis. Methods Mol Biol 498, 91\u2013103, https:\/\/doi.org\/10.1007\/978-1-59745-196-3_6 (2009).","journal-title":"Methods Mol Biol"},{"key":"53197_CR50","doi-asserted-by":"publisher","first-page":"6640","DOI":"10.1073\/pnas.120163297","volume":"97","author":"KA Datsenko","year":"2000","unstructured":"Datsenko, K. A. & Wanner, B. L. One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci USA 97, 6640\u20136645, https:\/\/doi.org\/10.1073\/pnas.120163297 (2000).","journal-title":"Proc Natl Acad Sci USA"},{"key":"53197_CR51","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1128\/CVI.00023-16","volume":"23","author":"O Rossi","year":"2016","unstructured":"Rossi, O. et al. Toll-Like Receptor Activation by Generalized Modules for Membrane Antigens from Lipid A Mutants of Salmonella enterica Serovars Typhimurium and Enteritidis. Clin Vaccine Immunol 23, 304\u2013314, https:\/\/doi.org\/10.1128\/CVI.00023-16 (2016).","journal-title":"Clin Vaccine Immunol"},{"key":"53197_CR52","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1007\/s12033-014-9804-7","volume":"57","author":"O Rossi","year":"2015","unstructured":"Rossi, O. et al. Comparison of Colorimetric Assays with Quantitative Amino Acid Analysis for Protein Quantification of Generalized Modules for Membrane Antigens (GMMA). Molecular Biotechnology 57, 84\u201393, https:\/\/doi.org\/10.1007\/s12033-014-9804-7 (2015).","journal-title":"Molecular Biotechnology"},{"key":"53197_CR53","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/S0022-1759(98)00170-7","volume":"221","author":"A Frey","year":"1998","unstructured":"Frey, A., Di Canzio, J. & Zurakowski, D. A statistically defined endpoint titer determination method for immunoassays. J Immunol Methods 221, 35\u201341 (1998).","journal-title":"J Immunol Methods"},{"key":"53197_CR54","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/nprot.2010.5","volume":"5","author":"A Roy","year":"2010","unstructured":"Roy, A., Kucukural, A. & Zhang, Y. I-TASSER: a unified platform for automated protein structure and function prediction. Nat Protoc 5, 725\u2013738, https:\/\/doi.org\/10.1038\/nprot.2010.5 (2010).","journal-title":"Nat Protoc"},{"key":"53197_CR55","doi-asserted-by":"publisher","first-page":"W379","DOI":"10.1093\/nar\/gkt331","volume":"41","author":"JP Ebejer","year":"2013","unstructured":"Ebejer, J. P., Hill, J. R., Kelm, S., Shi, J. & Deane, C. M. Memoir: template-based structure prediction for membrane proteins. Nucleic Acids Res 41, W379\u2013383, https:\/\/doi.org\/10.1093\/nar\/gkt331 (2013).","journal-title":"Nucleic Acids Res"},{"key":"53197_CR56","doi-asserted-by":"publisher","first-page":"W252","DOI":"10.1093\/nar\/gku340","volume":"42","author":"M Biasini","year":"2014","unstructured":"Biasini, M. et al. SWISS-MODEL: modelling protein tertiary and quaternary structure using evolutionary information. Nucleic Acids Res 42, W252\u2013258, https:\/\/doi.org\/10.1093\/nar\/gku340 (2014).","journal-title":"Nucleic Acids Res"},{"key":"53197_CR57","doi-asserted-by":"publisher","first-page":"W510","DOI":"10.1093\/nar\/gkp322","volume":"37","author":"P Benkert","year":"2009","unstructured":"Benkert, P., Kunzli, M. & Schwede, T. QMEAN server for protein model quality estimation. Nucleic Acids Res 37, W510\u2013514, https:\/\/doi.org\/10.1093\/nar\/gkp322 (2009).","journal-title":"Nucleic Acids Res"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53197-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53197-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T16:04:58Z","timestamp":1671293098000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-53197-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,19]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["53197"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-53197-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"type":"electronic","value":"2045-2322"}],"subject":[],"published":{"date-parts":[[2019,11,19]]},"assertion":[{"value":"6 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.R. and M.P. are permanent employees of the GSK group of companies. M.M. and M.S. were GSK employees at the time of the study. R.R. and M.P. are listed as inventors on patents owned by the GSK group of companies. Maricarmen Rojas-Lopez is a Marie Curie PhD Research Fellow with a grant from by ITN EID DISCo performed at GSK and INRA.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17014"}}